Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,878,926 papers from all fields of science
Search
Sign In
Create Free Account
nabilone
Known as:
nabilone [Chemical/Ingredient]
, Nabilon
, 3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a- hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo(b,d)pyran-9-one
Expand
A synthetic cannabinoid and dibenzopyrane derivative with anti-emetic activity. Although the mechanism of action has not been fully elucidated yet…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Broader (3)
Anti-Anxiety Agents
Antiemetics
Tetrahydrocannabinol
Cannabinoid Receptor Agonists [MoA]
Cannabinoids
Drug Allergy
Nausea
Expand
Narrower (1)
Cesamet
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Why support a separate medical access framework for cannabis?
Elizabeth A Cairns
,
M. Kelly
Canadian Medical Association Journal
2017
Corpus ID: 207399626
Medical access to cannabis was first granted in Canada in 1999, with several amendments leading to the current Access to Cannabis…
Expand
2005
2005
The effect of nabilone on neuropsychological functions related to driving ability: an extended case series
I. Kurzthaler
,
T. Bodner
,
+4 authors
W. Fleischhacker
Human psychopharmacology
2005
Corpus ID: 41345994
The primary goal of this prospective extended case series was to obtain the first data about the potential influence of nabilone…
Expand
2002
2002
The legalization of Cannabis for medical use.
A. Moffat
Science & justice : journal of the Forensic…
2002
Corpus ID: 2635013
1998
1998
Rat central ORL-1 receptor uncouples from adenylyl cyclase during membrane preparation
H. Okawa
,
R. Hirst
,
D. Smart
,
A. Mcknight
,
D. Lambert
Neuroscience Letters
1998
Corpus ID: 13013925
1989
1989
Nabilone as effective therapy for intractable nausea and vomiting in AIDS.
ST Green
,
D. Nathwani
,
DJ Goldberg
,
DH Kennedy
British Journal of Clinical Pharmacology
1989
Corpus ID: 6027806
Rapport d'un cas d'utilisation avec succes de nabilone comme antiemetique chez un patient victime de vomissements rebelles aux…
Expand
1987
1987
Species specificity in the metabolism of nabilone. Relationship between toxicity and metabolic routes.
H. Sullivan
,
G. Hanasono
,
W. Miller
,
P. Wood
Xenobiotica; the fate of foreign compounds in…
1987
Corpus ID: 1254636
The disposition of 14C-nabilone has been examined in dogs and monkeys; it is rapidly absorbed and extensively metabolized in both…
Expand
Review
1985
Review
1985
Nabilone. A preliminary review of its pharmacological properties and therapeutic use.
A. Ward
,
B. Holmes
Drugs
1985
Corpus ID: 72732320
Nabilone is a new orally active cannabinoid for the treatment of severe gastrointestinal toxicity associated with cancer…
Expand
Review
1985
Review
1985
Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
D. Cunningham
,
G. Forrest
,
M. Soukop
,
N. Gilchrist
,
I. T. Calder
,
C. McArdle
British medical journal
1985
Corpus ID: 40739562
1 Baker H, Wilkinson D. Psoriasis. In: Rook A, Wilkinson D, Ebling F, eds. Textbook of dermatology. 3rd ed. Oxford: Blackwell…
Expand
1983
1983
Comparison of Bronchial Effects of Nabilone and Terbutaline in Healthy and Asthmatic Subjects
H. Gong
,
D. Tashkin
,
B. Calvarese
Journal of clinical pharmacology
1983
Corpus ID: 7592056
Abstract: The acute bronchomotor effect of nabilone, a synthetic cannabinoid compound, was compared to that of terbutaline…
Expand
1979
1979
Suppression of Cancer Chemotherapy-Induced Vomiting in the Cat by Nabilone, a Synthetic Cannabinoid 1
S. W. London
,
L. McCarthy
,
H. L. Borison
Proceedings of the Society for Experimental…
1979
Corpus ID: 45842511
Summary and conclusion Nabilone, a synthetic cannabinoid, has been shown to have a unique spectrum of antiemetic activity in the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE